VNDA

HETLIOZ® (tasimelteon)

Non-24-Hour Sleep-Wake Disorder (Non-24)

Quarterly Sales (Approved)

Exp Date

November 6, 2020 (Est)

Amp Volatility Score

Catalyst Info & Data Links

TITLE: HETLIOZ® (tasimelteon) - Quarterly Sales

WHAT IS THE CATALYST EVENT?

  • Quarterly sales


WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?

  • November 6, 2020 (Est)


PRIOR DATA/EVENTS

PRESS RELEASE

COMPETITORS

  • HETLIOZ® (tasimelteon) - The first and only FDA-approved treatment for Non-24-Hour Sleep-Wake Disorder (Non-24).

MECHANISM OF ACTION / RATIONALE

  • The precise mechanism by which tasimelteon exerts its therapeutic effect in patients with Non- 24 is not known. Tasimelteon is an agonist at melatonin MT1 and MT2 receptors. These receptors are thought to be involved in the control of circadian rhythms (Learn more pg.6)

Updated by HC

#VNDA, #HETLIOZ, #tasimelteon, #Non_24, #Sleep_Wake_Disorder

Prior Data (click to view full image)

Chart

Trial Design / Revenue (click to view full image)

Chart

Recent Posts

See What The Community Is Saying - Click To See Full Post

Upcoming September 2020 COVID-...

Check out our AmpCards & #COVID19 catalyst tracker for investible small & mid-cap biopharma companies in the COVID therapeutics and vaccine race. Therapeutic candidate data from $VNDA, $BCRX, & $BSGM ...

VNDA - Interim Analysis from #...

#VNDA's interim analysis of the #ODYSSEY study demonstrated that hospitalized patients with #COVID-19 pneumonia improved sooner when treated with #tradipitant as compared to placebo. Summary of find...

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon